Exoskeleton Use in Acute Rehab Post Spinal Cord Injury; a Safety and Feasibility Study
1 other identifier
interventional
11
1 country
1
Brief Summary
This study will examine the safety and feasibility of using an exoskeleton in subjects who are less than 6 months post spinal cord injury (SCI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2016
CompletedStudy Start
First participant enrolled
June 1, 2016
CompletedFirst Posted
Study publicly available on registry
May 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedMay 16, 2019
May 1, 2019
1.7 years
April 20, 2016
May 14, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline cardiorespiratory status throughout each of the 25 sessions
Blood pressure, heart rate and peripheral oxygen saturation and will be used to identify any cardiovascular issues of orthostatic hypotension or autonomic dysreflexia.
Every 15 minutes during each training session including: pre and post initial stand, at 15 minute intervals during training and at the end of each of the 25 total sessions, on average of 2 months
Secondary Outcomes (6)
Skin integrity
At the beginning and end of each training session for 25 sessions, on average of 2 months
Falls
From onset to cessation of each training session for 25 sessions, on average of 2 months
Pain visual analogue scale
At the beginning and end of each training session for 25 sessions, on average of 2 months
Borg scale of perceived exertion
At the beginning, mid point (30 min) and end (60 min) of each training session for 25 sessions, on average of 2 months
10 meter walk test
Training sessions 1, 13 and 25 out of the 25 total sessions, on average of 2 months
- +1 more secondary outcomes
Study Arms (1)
Overground walking program
EXPERIMENTALStudy participant will be involved in an indoor, overground walking program using an exoskeleton wearable walking device under the supervision of a physiotherapist.
Interventions
This is an open study and so all participants involved with be using the exoskeleton to determine the safety and feasibility of its use during the acute rehabilitation phase.
Eligibility Criteria
You may qualify if:
- Individuals aged 15 and older with acute SCI (\<6 months post) Etiology of SCI can be traumatic or non traumatic Includes motor complete (AIS A,B) and motor incomplete (AIS C,D) at C7 or below.
- Participants must be able to follow 2 step commands Participants must be deemed medically stable by responsible physician or physiatrist
- Spine considered stable by surgeon
- Surgical wound is approximated and surrounding tissue appears healthy
- Participant does not require supplemental Oxygen
- Participant is able to have any IV or other lines disconnected.
- Must meet manufacturer's requirements for use of Ekso GT:
You may not qualify if:
- Range of motion (ROM) restrictions that would prevent a patient from achieving a normal, reciprocal gait pattern, or would restrict a patient from completing normal sit-to-stand or stand-to-sit transitions Spinal instability Untreated deep vein thrombosis (DVT) Decreased standing tolerance due to orthostatic hypotension Significant osteoporosis that prevents safe standing or may increase the risk of fracture caused by standing or walking Uncontrolled spasticity - score of 3 or higher on modified Ashworth Scale Uncontrolled Autonomic Dysreflexia (AD) Skin integrity issues on contact surfaces of the device or on surfaces that would prohibit sitting (sacrum, greater trochanter, proximal tibia)
- Upper leg length discrepancy greater than half an inch (\> .5") or lower leg discrepancy greater than three-quarters of an inch (\>.75") Cognitive impairments resulting in motor planning or impulsivity concerns Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foothills Medical Centre
Calgary, Alberta, T2N2T9, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chester Ho, MD
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 20, 2016
First Posted
May 9, 2017
Study Start
June 1, 2016
Primary Completion
February 1, 2018
Study Completion
February 1, 2018
Last Updated
May 16, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share